entertainment -WSS

entertainment

author：explore 2025-09-03 03:26:48 - browse：7564

Stephen Quake: "Our North Star for the next decade is understanding the mysteries of the cell." Chan Zuckerberg Initiative

SAN DIEGO — Decades ago, as a young physics Ph.D. student, Stephen Quake stumbled into the messy, dazzlingly complicated world of biology — and he’s stayed there ever since.

Quake, a professor of bioengineering and applied physics at Stanford, is a prolific academic whose discoveries have fueled the field of blood-based prenatal testing and the use of microfluidic chips, which allow scientists to quickly analyze DNA, RNA, proteins, and cells. He’s also head of science for the Chan Zuckerberg Initiative, or CZI, a company Mark Zuckerberg and Priscilla Chan founded in 2015 with the expressed intent to help “cure, prevent or manage all diseases by the end of this century.” The organization funds academic research and operates three biohubs in San Francisco, Chicago, and New York, each centered on goals such as building cells that can survey the body for signs of disease or deciphering the signals that drive inflammatory disease.

STAT sat down with Quake in front of an audience during the annual meeting of the Biotechnology Innovation Organization for a fireside chat about his pivot into the life sciences — and his second unexpected journey into the world of philanthropy.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Activists slam private health insurers over coverage restrictions
Next article： FDA proposes changes to key medical devices approval pathway

WSS

WATCH: Why do bright lights make us see spots?

4 missing after record

FDA approves first blood sugar monitor without finger pricks

Generate Biomedicines machine learning biotech raises $273M

White House touts steps to stem shortages of cancer treatments

Statins reduce cardiovascular risk in people living with HIV

Wikipedia

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

23andMe had bad news about my health. I wish a person had delivered it

FDA approves updated Covid vaccines

Apple is now the first public company to be valued at $3 trillion

Long Covid needs a new name — and a new frame

Supreme Court strikes down use of affirmative action

Transgender women dream of pregnancy via uterus transplants

Hollywood unions extend contract negotiations for actors

FDA proposes changes to key medical devices approval pathway

Bright Health sells Medicare Advantage business to Molina

How medical schools plan to diversify without affirmative action

knowledge

Private equity could exacerbate cardiology's overuse problem, experts fear

Severe heat forecast: Where scorching temperatures will persist over the next week

My chronic pain journey would have been easier knowing 5 things % STAT

Generate Biomedicines machine learning biotech raises $273M

How to protect coverage of PrEP

What to make of Biden’s latest efforts on cancer research

explore

focus

leisure time

hotspot